72
89. La Rosa JC, Grundy SM, Waters DD, Shear C, et al. Intensive lipid
lowering with atorvastatin in patients with stable coronary disease. N
Engl J Med. - 2005. - 352:1425-1435.
90. Lawlor D.A., Ebrahim S., Davey Smith G. Sex matters: secular,
geographical trends in sex differences in coronary heart disease
mortality. BMJ. - 2001. 323:541-545
91. Law M.R., Morris J.K., Wald NJ. Environmental tobacco smoke
exposure and ischemic heart disease: an evaluation of the evidence.
BMJ. - 1997. 315:973-980.
92. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R.. Age-
specific relevance of usual blood pressure to vascular mortality: a
meta-analysis of individual data for one million adults in 61
prospective studies. Lancet. - 2002. 360:1903-1913.
93. Lightwood J.M., Glantz S.A. Declines in acute myocardial infarction
after smoke free laws and individual risk attributable to secondhand
smoke. Circulation. - 2009. 120:1373-1379.
94. Linden W., Phillips M.J., Leclerc J.. Psychological treatment of
cardiac patients: a meta-analysis. Eur Heart J. - 2007. 28:2972-2984.
95. Linke A., Erbs S., Hambrecht R.. Effects of exercise training upon
endothelial function in patients with cardiovascular disease. Front
Biosci. - 2008. 13:424-432.
96. Lippi G., Maffulli N. Biological influence of physical exercise on
hemostasis. Semin Thromb Hemost. - 2009. 35:269-276.
97. Liu M, Counsell C, Sandercock P. Anticoagulants for preventing
recurrence fol-lowing ischaemic stroke or transient ischaemic attack.
Cochrane Database Syst Rev. - 2000. - 2:CD00024
98. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., et al. Blood
pressure, stroke, and coronary heart disease. Part 1, Prolonged
differences in blood pressure: prospective observational studies
corrected for the regression dilution bias. Lancet. - 1990. 335:765-774.
99. Malik V.S., Popkin B.M., Bray G.A., Despres J.P., Hu F.B. Sugar -
sweetened beverages, obesity, type 2 diabetes mellitus, and
cardiovascular disease risk. Circulation. - 2010. 94:1356-1364.
100. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., et al.
2007 ESH-ESC Practice Guidelines for the Management of Arterial
Hypertension: ESH-ESC Task Force on the Management of Arterial
Hypertension. J Hypertens. - 2007. 25:1751-1762.
101. Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, PerriD. Primary
prevention of cardiovascular mortality and events with statin
Klinik
protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
73
treatments: a network meta-analysis involving more than 65,000
patients. J Am Coll Cardiol. - 2008. - 52:1769-1781.
102. Mohr JP, Thompson JL, Lazar RM, Levin B, et al. A comparison of
warfarin and aspirin for the prevention of recurrent ischemic stroke. N
Engl J Med. - 2001. - 345:1444-1451.
103. Mollmann H., Liebetrau C., Nef H.M., Hamm C.W. The Swedish
paradox: or is there really no gender difference in acute coronary
syndromes? Eur Heart J. - 2011. 32:3070-3072.
104. Mosca L., Banka C.L., Benjamin E.J., Berra K., Bushnell C., et al.
Evidence-based guidelines for cardiovascular disease prevention in
women: 2007 update. Circulation. - 2007. 115:1481-1501.
105. Mozaffarian D., Rimm E.B. Fish intake, contaminants, and human
health: evaluating the risks and the benefits. JAMA. - 2006. 296:1885-
1899.
106. Mozaffarian D., Katan M.B., Ascherio A., Stampfer M.J., Willett W.C.
Trans fatty acids and cardiovascular disease. N Engl J Med. - 2006.
354:1601-1613.
107. National Institute for Health and Clinical Excellence [Electronic
resource]: NICE Public Health Guidance 10. Smoking Cessation
Services in Primary Care, Pharmacies, Local Authorities and
Workplaces, Particularly for Manual Working Groups, Pregnant
Women and Hard to Reach Communities. - 2008. - Available at:
http://www.nice.org.uk/nicemedia/pdf/PH010guidance.pdf
(04.02.2014)
108. Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, et al. HMG
CoA reductase inhibitors (statins) for kidney transplant recipients.
Cochrane Database Syst Rev. - 2009. - 2: CD005019.
109. Neaton JD, Blackburn H, Jacobs D, Kuller L, et al. Serum cholesterol
level mortality findings for men screened in the Multiple Risk Factor
Intervention Trial. Multiple Risk Factor Intervention Trial Research
Group. Arch Intern Med - 1992.- 152:1490-1500.
110. Neil A, Cooper J, Betteridge J, Capps N, McDowell I, et al.
Reductions in all-cause, cancer, and coronary mortality in statintreated
patients with heterozygous familial hypercholesterolaemia: a
prospective registry study. Eur Heart J. - 2008. - 29:2625-2633.
111. Neter J.E., Stam B.E., Kok F.J., Grobbee D.E., Geleijnse J.M.
Influence of weight reduction on blood pressure: a meta-analysis of
randomized controlled trials. Hypertension. - 2003. 42:878-884.
112. O’Connor C.M., Whellan D.J., Lee K.L., Keteyian S.J., Cooper L.S.,
.Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, et al.
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.